Ranitidine hydrochloride and Tarceva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine hydrochloride (ranitidine hydrochloride) and Tarceva (erlotinib hydrochloride). Common drug interactions include spinal fracture among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine hydrochloride and Tarceva. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

On Jul, 31, 2026

13 people who take Ranitidine hydrochloride and Tarceva together, and have interactions are studied.

Ranitidine hydrochloride and Tarceva drug interactions.

What are the common drug interactions of Ranitidine Hydrochloride and Tarceva, by gender? *:

female:

Spinal fracture (fracture in one of vertebrae)
Diarrhoea
Rash
Adnexa uteri mass (ovarian cysts)
Anaemia (lack of blood)
Death
Disease progression
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Hydronephrosis (water inside the kidney)
Hypertension (high blood pressure)

male:

Death
Acne (skin problems that cause pimples)
Hypertension (high blood pressure)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Oxygen saturation decreased
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Pancreatitis (inflammation of pancreas)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the common drug interactions of Ranitidine Hydrochloride and Tarceva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Adnexa uteri mass (ovarian cysts)
Disease progression
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Hydronephrosis (water inside the kidney)
Hypertension (high blood pressure)
Jaundice cholestatic
Metastases to bone (cancer spreads to bone)
Metastases to lymph nodes (cancer spreads to lymph node)
Metastases to pancreas (cancer spreads to pancreas)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

60+:

Spinal fracture (fracture in one of vertebrae)
Anaemia (lack of blood)
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Oxygen saturation decreased
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Pancreatitis (inflammation of pancreas)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Pulmonary mass

What are the existing conditions these people have? *

Pain: 3 people, 23.08%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 23.08%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 23.08%
Gastric Ulcer (stomach ulcer): 3 people, 23.08%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 15.38%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 2 people, 15.38%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 7.69%
Malignant Respiratory Tract Neoplasm (cancer tumour of respiratory tract): 1 person, 7.69%
Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 7.69%
Lung Adenocarcinoma Recurrent (reoccurrence of a form of non-small cell lung cancer): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and Tarceva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously